Home › GSK, Pfizer must lower price of vital vaccine: Medecins sans Frontieres
 

Keywords :   


GSK, Pfizer must lower price of vital vaccine: Medecins sans Frontieres

2015-01-25 03:07:53| Biotech - Topix.net

Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Medecins sans Frontieres . In a report on vaccine pricing, MSF says British company GlaxoSmithKline and US giant Pfizer should slash the price of the vaccines to US$5 per child in developing countries.

Tags: price lower sans vital

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.06Atlantic Tropical Weather Outlook
16.06Eastern North Pacific Tropical Weather Outlook
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06This Week in Agribusiness, June 15, 2024
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06With Gratitude for a Job Well Done
More »